Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

67%

Ph phase_3

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

4(66.7%)

Phase 3Large-scale testing

2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(4)

Detailed Status

unknown4

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 24 (66.7%)

Phase 32 (33.3%)

Trials by Status

completed233%

unknown467%

Recent Activity

0 active trials

Showing 5 of 6

unknownphase_2

Clinical Trials (6)

Showing 6 of 6 trials

NCT03385096Phase 2

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Unknown

NCT00002835Phase 3

Combination Chemotherapy in Treating Patients With Lymphoma

Completed

NCT03733327Phase 2

BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

Unknown

NCT03623087Phase 3

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Unknown

NCT03229616Phase 2

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Unknown

NCT00165139Phase 2

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6